Central Trust Company’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $282K | Buy |
5,848
+412
| +8% | +$19.2K | 0.01% | 529 |
|
|
2025
Q4 | $263K | Sell |
5,436
-48
| -0.9% | -$2.38K | 0.01% | 529 |
|
|
2025
Q3 | $259K | Sell |
5,484
-670
| -11% | -$32.3K | 0.01% | 541 |
|
|
2025
Q2 | $297K | Sell |
6,154
-100
| -2% | -$5.11K | 0.01% | 493 |
|
|
2025
Q1 | $347K | Sell |
6,254
-19
| -0.3% | -$1.03K | 0.01% | 464 |
|
|
2024
Q4 | $303K | Sell |
6,273
-27
| -0.4% | -$1.37K | 0.01% | 495 |
|
|
2024
Q3 | $363K | Sell |
6,300
-41
| -0.6% | -$2.21K | 0.01% | 457 |
|
|
2024
Q2 | $308K | Sell |
6,341
-540
| -8% | -$26K | 0.01% | 485 |
|
|
2024
Q1 | $334K | Sell |
6,881
-419
| -6% | -$20.5K | 0.01% | 484 |
|
|
2023
Q4 | $363K | Buy |
7,300
+143
| +2% | +$6.99K | 0.01% | 450 |
|
|
2023
Q3 | $384K | Buy |
7,157
+2,230
| +45% | +$119K | 0.01% | 438 |
|
|
2023
Q2 | $266K | Hold |
4,927
| – | – | 0.01% | 505 |
|
|
2023
Q1 | $268K | Sell |
4,927
-121
| -2% | -$5.88K | 0.01% | 496 |
|
|
2022
Q4 | $244K | Hold |
5,048
| – | – | 0.01% | 494 |
|
|
2022
Q3 | $192K | Buy |
5,048
+419
| +9% | +$18.7K | 0.01% | 529 |
|
|
2022
Q2 | $232K | Hold |
4,629
| – | – | 0.01% | 503 |
|
|
2022
Q1 | $238K | Buy |
4,629
+724
| +19% | +$37.4K | 0.01% | 541 |
|
|
2021
Q4 | $196K | Sell |
3,905
-1,085
| -22% | -$53.7K | 0.01% | 585 |
|
|
2021
Q3 | $241K | Sell |
4,990
-82
| -2% | -$4.17K | 0.01% | 514 |
|
|
2021
Q2 | $267K | Buy |
5,072
+81
| +2% | +$4.23K | 0.01% | 490 |
|
|
2021
Q1 | $246K | Sell |
4,991
-4,195
| -46% | -$202K | 0.01% | 482 |
|
|
2020
Q4 | $446K | Sell |
9,186
-19,167
| -68% | -$945K | 0.02% | 381 |
|
|
2020
Q3 | $1.42M | Sell |
28,353
-923
| -3% | -$47.5K | 0.06% | 212 |
|
|
2020
Q2 | $1.5M | Buy |
29,276
+1,046
| +4% | +$50.8K | 0.08% | 195 |
|
|
2020
Q1 | $1.23M | Buy |
28,230
+479
| +2% | +$22.9K | 0.08% | 195 |
|
|
2019
Q4 | $1.39M | Buy |
27,751
+13,855
| +100% | +$649K | 0.07% | 211 |
|
|
2019
Q3 | $643K | Buy |
13,896
+6,869
| +98% | +$296K | 0.04% | 302 |
|
|
2019
Q2 | $298K | Buy |
7,027
+1,092
| +18% | +$46.4K | 0.02% | 396 |
|
|
2019
Q1 | $263K | Buy |
5,935
+1,010
| +21% | +$43.3K | 0.02% | 397 |
|
|
2018
Q4 | $213K | Buy |
4,925
+350
| +8% | +$15.4K | 0.01% | 423 |
|
|
2018
Q3 | $205K | Sell |
4,575
-1,000
| -18% | -$42.7K | 0.01% | 468 |
|
|
2018
Q2 | $223K | Sell |
5,575
-3,169
| -36% | -$125K | 0.01% | 443 |
|
|
2018
Q1 | $350K | Sell |
8,744
-643
| -7% | -$26.8K | 0.02% | 381 |
|
|
2017
Q4 | $403K | Sell |
9,387
-301
| -3% | -$13.9K | 0.02% | 368 |
|
|
2017
Q3 | $483K | Sell |
9,688
-1,595
| -14% | -$77.2K | 0.03% | 325 |
|
|
2017
Q2 | $540K | Sell |
11,283
-3,821
| -25% | -$183K | 0.04% | 304 |
|
|
2017
Q1 | $683K | Sell |
15,104
-3,133
| -17% | -$133K | 0.05% | 268 |
|
|
2016
Q4 | $738K | Sell |
18,237
-1,878
| -9% | -$74K | 0.05% | 259 |
|
|
2016
Q3 | $768K | Sell |
20,115
-703
| -3% | -$28.2K | 0.06% | 252 |
|
|
2016
Q2 | $872K | Buy |
20,818
+3,755
| +22% | +$154K | 0.07% | 239 |
|
|
2016
Q1 | $685K | Buy |
17,063
+2,149
| +14% | +$86.3K | 0.05% | 255 |
|
|
2015
Q4 | $637K | Buy |
14,914
+2,155
| +17% | +$99.1K | 0.05% | 256 |
|
|
2015
Q3 | $606K | Buy |
12,759
+150
| +1% | +$7.64K | 0.05% | 257 |
|
|
2015
Q2 | $624K | Buy |
12,609
+971
| +8% | +$49.2K | 0.05% | 265 |
|
|
2015
Q1 | $575K | Buy |
11,638
+239
| +2% | +$11.4K | 0.05% | 275 |
|
|
2014
Q4 | $520K | Sell |
11,399
-1,807
| -14% | -$87.7K | 0.04% | 288 |
|
|
2014
Q3 | $745K | Buy |
13,206
+417
| +3% | +$22.4K | 0.06% | 243 |
|
|
2014
Q2 | $680K | Sell |
12,789
-1,288
| -9% | -$68.4K | 0.05% | 261 |
|
|
2014
Q1 | $735K | Sell |
14,077
-3,296
| -19% | -$167K | 0.06% | 243 |
|
|
2013
Q4 | $931K | Sell |
17,373
-6,055
| -26% | -$312K | 0.08% | 214 |
|
|
2013
Q3 | $1.19M | Sell |
23,428
-16,823
| -42% | -$856K | 0.11% | 170 |
|
|
2013
Q2 | $2.07M | Buy |
+40,251
| New | +$2.14M | 0.2% | 110 |
|
Other funds holding SNY
MIP
Central Trust Company's SNY Position: Q1 2026 in Review
Central Trust Company increased its Sanofi (SNY) stake by 7.6% in Q1 2026, buying an estimated $19.2K and bringing the position to 5,848 shares worth $282K. The position accounts for 0.01% of the portfolio, ranked #529.
Central Trust Company first reported a position in SNY in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.07M in Q2 2013. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.
- Central Trust Company held 5,848 shares of Sanofi worth $282K as of Q1 2026.
- Central Trust Company bought 412 Sanofi shares in Q1 2026, an estimated $19.2K.
- Sanofi made up 0.01% of Central Trust Company's portfolio in Q1 2026, its #529 holding.
- Central Trust Company first reported a position in Sanofi in Q2 2013 and has held it in 52 quarters since.
- Central Trust Company's Sanofi position peaked at $2.07M in Q2 2013.
- 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.
Based on Central Trust Company's 13F filing for Q1 2026, filed 17 Apr 2026.